Alanine Aminotransferase (ALT)
Why in News?Alanine Aminotransferase (ALT) was recently in the news after researchers reported that elevated ALT levels may serve as an early biomarker for detecting liver damage and assessing the progression of metabolic disorders, including non-alcoholic fatty liver disease (NAFLD).
Background
- Alanine Aminotransferase (ALT) is an enzyme primarily found in liver cells and plays an important role in amino acid metabolism.
- Damage or inflammation of liver cells causes ALT to leak into the bloodstream, making it a key indicator of liver health.
- ALT catalyses the conversion of alanine into pyruvate, which is essential for energy production.
- The enzyme is present mainly in the liver, but small amounts are also found in the kidneys, heart and muscles.
- An ALT blood test is commonly used to detect liver injury and monitor the effectiveness of treatment for liver diseases.
- Elevated ALT levels often indicate liver conditions such as hepatitis, fatty liver disease, cirrhosis or drug-induced liver injury.
- ALT is considered more liver-specific than Aspartate Aminotransferase (AST) for assessing liver damage.
- The test is simple, cost-effective and widely used as part of routine liver function tests (LFTs).
- Early detection of abnormal ALT levels helps in the timely diagnosis and management of liver diseases.
- Regular monitoring of ALT is important for patients receiving medications that may affect liver function.
- ALT testing supports public health efforts to address the growing burden of metabolic and lifestyle-related liver diseases.
- Elevated ALT levels alone cannot confirm a specific liver disease and require further diagnostic evaluation.
- Some individuals with chronic liver disease may have normal ALT levels despite significant liver damage.
- Recent studies have highlighted ALT as a valuable biomarker for the early detection of metabolic dysfunction-associated steatotic liver disease (MASLD) and related complications.
- Researchers are exploring the combined use of ALT with other biomarkers to improve the accuracy of liver disease diagnosis.
- Greater awareness and routine liver screening should be promoted among high-risk populations.
- Early diagnosis through ALT testing, combined with lifestyle modifications and timely treatment, can reduce the burden of chronic liver diseases.
- Continued research should focus on improving diagnostic accuracy by integrating ALT with advanced biomarkers and imaging techniques.
